As Senate Finance Committee Convenes on Healthcare Costs, First Do No Harm
As the United States Senate Finance Committee convenes today for a meeting entitled "The Rising Cost of Health Care: Considering Meaningful Solutions for All Americans," the enduring adage of medical care applies: Do no harm.
Specifically, as we've detailed at CFIF, we must especially avoid potentially catastrophic ideas like drug price controls (whether through so-called "Most Favored Nation" (MFN) programs or any other) and violations of patent and intellectual property (IP) protections in which the United States leads the world. Indeed, our more free-market approach explains why America leads the world in lifesaving healthcare innovation, accounting for an astonishing two-thirds of all new drugs introduced to the world each year:
The reasons that MFN schemes would only exacerbate…[more]
There are a number of ways to look at Monday’s announcement that the Treasury Department is going to delay ObamaCare’s employer mandate — requiring firms to provide health insurance for their employees — until 2016 for companies with between 50 and 99 employees.
You can consider it raw politics, a shameless exercise in taking a vital issue off the table for this year’s midterm elections, where Democrats are already looking embattled.
You can look at it as further evidence of this Administration’s lawlessness, another major change to the law enacted without…